Alerts will be sent to your verified email
Verify Email
MEDIORG
|
Medicamen Organics
|
Lasa Supergenerics
|
Kabra Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.97 % | -8.32 % | 65.41 % |
|
5yr average Equity Multiplier
|
3.29 | 1.44 | -11.28 |
|
5yr Average Asset Turnover Ratio
|
0.76 | 0.77 | 0.0 |
|
5yr Avg Net Profit Margin
|
3.89 % | -8.22 % | 0.0 |
|
Price to Book
|
0.0 | 0.61 | 2.03 |
|
P/E
|
15.56 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-32.99 Days | 11.27 Days | 0.0 |
|
Inventory Days
|
70.3 Days | 46.83 Days | 0.0 |
|
Days Receivable
|
198.36 Days | 10.61 Days | 0.0 |
|
Days Payable
|
321.34 Days | 83.41 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
3.25 | -18.91 | -836.53 |
|
5yr Avg ROCE
|
15.06 % | 1.03 % | 64.57 % |
|
5yr Avg Operating Profit Margin
|
9.86 % | 9.99 % | 0.0 |
|
5 yr average Debt to Equity
|
1.18 | 0.2 | -6.16 |
|
5yr CAGR Net Profit
|
51.57 % | n/a | 65.28 % |
|
5yr Average Return on Assets
|
2.68 % | -5.59 % | -21.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
59.73 % | 53.65 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 20.66 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.04 % | 9.87 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Medicamen Organics
|
Lasa Supergenerics
|
Kabra Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|